市场调查报告书
商品编码
1198009
气动止血带市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)Pneumatic Tourniquets Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内(2022 年至 2027 年),气动止血带市场预计将以 7.1% 左右的复合年增长率增长。
COVID-19 引发了全球突发公共卫生事件,几乎影响到每一个企业和行业。 预计长期影响将影响预测期内行业的增长。 锁定期间对择期手术的限制和供应链中断影响了全球外科手术市场,对市场产生了负面影响。
题为“WALANT 技术与局部区域麻醉在掌骨和指骨骨折手术治疗中的比较”的文章发表于 2021 年 12 月。 根据 COVID-19 危机的教训,在 COVID-19 大流行期间,Wide Awake Local Anesthesia No Tourniquet (WALANT) 是一种避免使用止血带并允许局部注射麻醉剂和肾上腺素的麻醉技术。 这种 WALANT 已被证明是一种安全有效的手部骨折手术方法,可确保根据 COVID-19 进行手术治疗。 为了避免病毒传播,护理中心采取了替代措施,这对所研究的市场产生了负面影响。
然而,近年来,骨科和整形手术数量的增加、意外事故和跌倒的激增,以及随之而来的退行性骨病患病率的上升,推动了研究市场的增长。 例如,由国家卫生服务 (NHS) 提供的“2020-21 年医院事故和紧急情况活动”指出,2020-21 年将有 1440 万人到 NHS 医院事故和紧急情况 (A&E) 部门就诊。事实已经如此。 由于此类事故导致的紧急住院负担增加,预计将增加对伤口护理手术的需求,从而推动对无血干式手术气动止血带的需求。 预计这将促进所研究市场的增长。
此外,气动止血带在世界各地的手足手术中得到常规和安全的使用。 使用这些止血带会改变正常的生理机能。 这些止血带的使用是骨科和整形外科的常见做法。 骨科手术和其他增强手术的兴起预计将推动静脉局部麻醉 (IVRA),从而推动所研究市场的增长。
此外,最近大公司的收购和战略行动增加了对气动止血带的需求。 例如,2020 年,Research & Dutrillaux 收购了 Electro Concept Medical,以集中其研发、生产和分销技能。 这些领先公司的战略活动预计将推动所研究市场的增长。
但是,预计在手术期间缺乏熟练的专业人员来处理该系统,这将阻碍预测期内的市场增长。
气动止血带可以最大限度地减少动脉暴露、夹层和操作,并可以降低因夹紧胫骨血管而引起痉挛和受伤的风险。 这些止血带通常用于肢体手术,例如骨科和整形外科。
由于骨科疾病和其他退行性骨病的增加,预计在预测期内,按应用划分的骨科手术领域将随着增长而增长。 预计这些疾病需要更好的手术护理,以提供干燥的手术野并限制肢体手术期间的术中出血。 因此,这有望推动所研究市场的增长。
这一细分市场的增长预计将受到骨关节炎等目标疾病患病率上升以及膝关节和髋关节置换手术数量增加的推动。 经济合作与发展组织 (OECD) 于 2021 年 11 月更新的健康统计数据显示,意大利每 10 万人中进行了超过 193.9 次髋关节置换手术。 另一方面,奥地利、瑞士和比利时同年分别进行了每10万人口294.9、312.9和283.3次髋关节置换手术。
此外,根据加拿大健康信息研究所2021年6月的更新报告,2019年至2020年,加拿大共有63,496例髋关节置换术和7例膝关节置换术,据说已经进行了5,073例。 与上一年相比,这意味着髋关节增加了 2.4%,膝关节减少了 0.4%。 因此,全球骨科疾病患病率上升预计将推动该行业的增长。
因此,骨科手术的应用正在增长,预计在预测期内将出现显着增长。 因此,它正在推动研究市场的增长。
该地区老年人口的增加、医疗基础设施、更好的报销政策以及骨科和其他疾病负担的增加等因素预计将推动北美气动止血带市场的增长。
气动止血带常用于骨科手术,以实现近乎不流血的手术和最佳手术野,或在手术过程中提供局部麻醉。 根据美国疾病控制与预防中心 (CDC) 于 2021 年 10 月更新的《全国关节炎数据与统计》,美国 (US) 约有四分之一的成年人 (23.7%),即约 5850 万人,是医生。据报导被诊断出患有关节炎 到 2040 年,美国 7840 万 18 岁及以上的成年人(占成年人口总数的 25.9%)将被医生诊断为关节炎。 预计这将增加骨科手术的机会,并推动该国研究市场的增长。
此外,美国在建设和扩建医院方面投入更多。 例如,2021 年 10 月,麻省总医院获得波士顿规划和发展委员会的批准,扩建 100 万平方英尺,耗资 20 亿美元。 此外,2021 年 10 月,Penn Medicine 完成了美国最大的医院项目之一,耗资 16 亿美元在费城开设了一家医院。 这些医院扩建和建设支出的增加预计将创造对医疗设备的需求,并推动该国研究市场的增长。
此外,骨关节炎是一种退行性疾病,会随着时间的推移而恶化,并且通常会导致慢性疼痛。 The Arthritis Facts and Figures,2021 年 9 月更新,由关节炎协会出版,发现骨关节炎是最常见的关节炎形式,超过 400 万加拿大人患有骨关节炎 (OA)。据报导,大约每 7 名加拿大人中就有 1 人成年人患有这种进行性和痛苦的疾病。 消息人士还提到,超过 30% 的受试者被诊断出不仅患有 OA,还患有情绪障碍和焦虑症。 预计此类骨退行性疾病的流行将推动对根治性骨科手术的需求。 由于气动止血带主要用于骨科手术,预计骨科手术的增加将增加对气动止血带的需求。 因此,预计它将推动加拿大调查市场的增长。
因此,由于上述因素,预计北美地区在预测期内将呈现强劲增长,从而推动研究市场的增长。
在当前情况下,市场参与者不断增加的策略正在推动全球空气止血带市场。 由于存在数量有限的大型参与者,该市场本质上具有竞争性,并且在全球范围内得到整合。 Stryker、Zimmer Biomet、Ulrich medical、AneticAid、VBM Medizintechnik GmbH、Dessillions & Dutrillaux (D&D)、DSMAREF、Hangzhou Kimislab、Shanghai HSBC Medical Equipment、Jiangsu Qianjing Medical Equipment等均处于领先地位。
The pneumatic tourniquets market is anticipated to witness a CAGR of nearly 7.1% during the forecast period (2022-2027).
COVID-19 has created a global public health emergency that has affected almost every business and industry. The long-term effects are projected to have an impact on the industry growth during the forecast period. Limitations on elective surgical procedures and disruption of the supply chain during lockdown have affected the market for surgical procedures worldwide and impacted the market negatively.
An article published in December 2021 titled "WALANT technique versus locoregional anesthesia in the surgical management of metacarpal and phalangeal fractures: Lessons from the COVID-19 crisis, the COVID-19 pandemic" mentioned that Wide Awake Local Anesthesia No Tourniquet (WALANT) is an anesthetic method that enables the use of a local injection of anesthetic and epinephrine, avoiding the use of a tourniquet. This WALANT proved to be a safe and effective method in hand fracture surgery, ensuring access to surgical care in the COVID-19 perspective. To avoid the spread of the virus, care centers have approached alternatives that impacted the studied market negatively.
However, the increasing number of orthopedic and plastic surgeries performed, the surge in accidental injuries and falls, and the subsequent rise in the prevalence of degenerative bone diseases have driven the studied market growth in recent years. For instance, "Hospital Accident & Emergency Activity, 2020-21", provided by National Health Services (NHS), states that in the year 2020-21, there were 14.4 million attendances in Accident and Emergency (A&E) departments in NHS hospitals. This increasing burden of accident emergency admissions is anticipated to increase the demand for wound care surgeries, hence driving the demand for pneumatic tourniquets for bloodless and dry surgical procedures. This is expected to boost the growth of the studied market.
Furthermore, pneumatic tourniquets are routinely and safely used in limb surgeries throughout the world. The application of these tourniquets alters normal physiology. The use of these tourniquets is a common practice in orthopedic and plastic surgeries. The increase in plastic surgery and other augmentation procedures is anticipated to drive intravenous regional anesthesia (IVRA), driving the growth of the studied market.
Moreover, recent acquisitions and strategic steps taken by major players are increasing the demand for pneumatic tourniquets. For instance, in 2020, Dessillions & Dutrillaux acquired Electro Concept Medical to pool the skills of research and development, production, and distribution. These strategic activities by major players in anticipated to drive the growth of the studied market.
However, the lack of skilled professionals to handle the systems during the surgery is anticipated to hinder the market growth over the forecast period.
The pneumatic tourniquets allow for minimal exposure, dissection, and handling of the arteries, and it may decrease the risk of spasms or injury caused by clamping of the tibial vessels. These tourniquets are generally used in limb surgeries, be it orthopedic or plastic surgeries.
The orthopedic surgery by application segment is anticipated to witness growth over the forecast period owing to increasing orthopedic conditions and other degenerative bone diseases. Both the prevalence is expected to demand better surgical care, which can provide a dry operative field and limit intraoperative blood loss during extremity surgery. Hence, this is expected to drive the growth of the studied market.
The growth of the segment is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis and the growing number of knee and hip replacement surgeries. The Organization for Economic Co-operation and Development (OECD) Health statistics data updated in November 2021 shows that there were over 193.9 hip replacement surgeries performed per 100,000 population in Italy. While over 294.9, 312.9, and 283.3 hip replacement surgeries were performed per 100,000 population in Austria, Switzerland, and Belgium, respectively, in the same year.
In addition to that, the Canadian Institute for Health Information's updates from June 2021 report shows that in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed. This represents a 2.4% increase for hips and a 0.4% decrease for knees compared with the previous years. This rising prevalence of orthopedic conditions worldwide is anticipated to drive the growth of the segment.
Hence, the orthopedic surgery by application segment is growing, and it is expected to have significant growth over the forecast period. Hence, driving the growth of the studied market.
Factors such as the increasing geriatric population across the region, healthcare infrastructure, better reimbursement policies, and the increasing burden of orthopedics and other diseases are anticipated to drive the growth of the North American pneumatic tourniquet market.
The pneumatic tourniquets are commonly used in orthopedic surgeries to achieve a nearly bloodless surgery and an optimal operating field or when administering regional anesthesia during surgery. The National Arthritis Data and Statistics updated in October 2021 by the Centre for Disease Control and Prevention (CDC) reported that about 1 in 4 adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis in the United States (US). The source also stated that, by the year ended 2040, 78.4 million adults aged 18 years and older (25.9% of the projected total adult population) are expected to have doctor-diagnosed arthritis in the US. This is expected to create opportunities for more orthopedic surgeries, driving the growth of the studied market in the country.
Moreover, the expenditure on hospital construction and expansion is increasing in the United States. For instance, in October 2021, Massachusetts General Hospital received approval from the Boston Planning and Development Agency board for a one-million-square-foot with USD 2 billion expansion. In addition to that, in October 2021, Penn Medicine opened a hospital in Philadelphia worth USD 1.6 billion, which marked the completion of one of the largest hospital projects in the United States. These rising expenditure on the expansion and construction of hospitals is expected to generate demand for medical devices and are anticipated to drive the growth of the studied market in the country.
Furthermore, osteoarthritis is a degenerative disease that worsens over time and often results in chronic pain. The Arthritis Facts and Figures updated in September 2021, published by the Arthritis Society, reported that osteoarthritis is the most common form of arthritis, and more than 4 million Canadians have osteoarthritis (OA), and about 1 in 7 Canadian adults live with this progressive and painful disease. The source also mentioned that more than 30% target population is diagnosed with a mood or anxiety disorder as well as OA. This prevalence of the degenerative bone disease is anticipated to drive the demand for orthopedic surgeries for treatment. As pneumatic tourniquets have the primary application in orthopedic surgeries, the increase in orthopedic surgeries is expected to increase the demand for pneumatic tourniquets. Hence, it is anticipated to drive the growth of the studied market in Canada.
Therefore, owing to the aforementioned factors, the North American region is expected to witness strong growth over the forecast period driving the growth of the studied market.
In the current scenario, the strategies by the market players are increasing, and it's fueling the global pneumatic tourniquet market. The market is competitive in nature and globally consolidated due to the presence of limited major players in the market. Stryker, Zimmer Biomet, Ulrich medical, AneticAid, VBM Medizintechnik GmbH, Dessillions & Dutrillaux (D&D), DSMAREF Co.Ltd., Hangzhou Kimislab Co., Ltd., Shanghai Huifeng Medical Instrument Co., Ltd., Jiangsu Qianjing Medical Equipment Co., Ltd are some of the major players among others.